share_log

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 12 05:43
Summary by Futu AI
Flagship Ventures Fund IV-Rx, L.P., an affiliate of Moderna, Inc., is set to sell 32,763 shares of Moderna's common stock, with an aggregate market value of approximately $4.86 million, on June 11, 2024. These shares were originally acquired on December 28, 2011, as part of a pre-IPO venture stage investment directly from the issuer, with cash payment. Over the past three months, Flagship Ventures has sold 200,000 shares of Moderna, generating total gross proceeds of $24.04 million.
Flagship Ventures Fund IV-Rx, L.P., an affiliate of Moderna, Inc., is set to sell 32,763 shares of Moderna's common stock, with an aggregate market value of approximately $4.86 million, on June 11, 2024. These shares were originally acquired on December 28, 2011, as part of a pre-IPO venture stage investment directly from the issuer, with cash payment. Over the past three months, Flagship Ventures has sold 200,000 shares of Moderna, generating total gross proceeds of $24.04 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.